Verdict No. 3104 · Search date 2026-09-15 · Methodology v1.0

Biotin , sole-active oral product,
does it really help with Reduction of recurrent brittle-nail breakage events over a standardized observation period?

Name: Verdict 3104 · Does oral biotin alone reduce how often brittle nails break?
Creator: Chamgap
Published: 2026-09-15

30-Second Summary

Evidence Grade ? · Safety caution

ChatGPT source review and self-verification · Codex technical integration

The eligible sole-active product’s exact chemical form, formulation, dose, frequency, duration, adherence and total dietary/concurrent intake; diagnostic and deficiency tests; and arm-specific event counts, time at risk, denominators, effect, CI, P value and MCID are not verified. Unknowns were not filled with 0 or normal values; no graph reconstruction, unit conversion or event-rate calculation was performed.

Safety is Caution. The inherited NIH material describes interference with selected thyroid tests within 24 hours of a single 10 mg dose and with selected TSH/NT-proBNP assays in 6 healthy people taking 10 mg/day for 1 week. FDA warns of falsely low results in susceptible troponin assays. No universal assay risk rate or stopping interval is specified. Supplement doses are not individual dosing, stopping or test-scheduling instructions. Adequate intake is not a brittle-nail treatment dose, and no established upper limit does not mean unlimited safety. Long-term, pregnancy, lactation, pediatric and hepatic/renal safety for this use, and arm-specific adverse events and discontinuations, remain unverified. Assay interference was not used as an efficacy penalty or efficacy evidence.

What the
research showsWithin the documented search, no directly eligible human comparative result was verified for sole-active oral biotin reducing breakage-event frequency over a standardized observation window. The ? grade and null score do not mean no effect or no studies worldwide.

What the
ads claimImproved hardness/thickness or mixture results do not establish fewer breakage events with biotin alone.

◎

Four separate assessment dimensions

Effect direction and size	No directly eligible between-group recurrent nail-breakage event-frequency result for oral biotin monotherapy was verified
Evidence certainty	? is scoped direct-evidence uncertainty, not no effect
Applicability	Adults with general brittle nails; fingernail and toenail strata separate; oral biotin as the sole active ingredient; matched-background placebo, no treatment, or usual care
Safety	Caution

B / P / null / null / null / null / null; score and strength count null

Useful facts when choosing a product

Adults with general brittle nails are assessed in separate fingernail and toenail strata. Confirmed biotin-deficiency correction and specific disease, trauma or drug-related groups are not pooled. An unreported baseline biotin status is not presumed sufficient.

Chamgap Semantic Classification Code

Permanent code issued

S.biotin.oral.adult-brittle-nail-breakage-event-frequency.reduce.placebo-no-treatment-or-usual-care

Substances and nutrients > Biotin (vitamin B7), sole active ingredient > Oral > Nail-breakage event frequency per person over a standardized period in adults with general brittle nails > Reduction claim > Matched-background placebo, no treatment, or usual care

Fingernail and toenail strata remain separate and only recurrent breakage-event frequency is fixed. Thickness, hardness, severity, responder proportions, photographs, and other substances such as collagen remain separate boundaries. The code identifies the intervention and claim; it never contains the evidence grade, score, or safety result.

Download semantic index (JSON) · Codebook v1

⌘

Exact Claim Classification

These independent facets prevent evidence from different forms, routes, populations, effects, and comparators from being mixed.

Intervention class	S · Supplement or nutraceutical
Canonical ingredient or intervention	Biotin (vitamin B7), sole active ingredient
Source or part used	Not verified: origin, exact chemical form and manufacturing source of an eligible product.
Formulation or processing	Sole-active oral product is the question boundary; tablet/capsule, excipients, batch and purity not verified.
Route	Oral; topical/injectable products and effects of the topical product itself excluded.
Dose	Not verified: eligible dose, frequency, total dietary intake and concurrent supplements.
Duration	Not verified: actual treatment duration and prespecified breakage observation window must be established separately.
Population	Adults with general brittle nails; fingernail and toenail strata separate. Confirmed deficiency correction and specific secondary causes excluded; unreported biotin status not presumed normal.
Effect or condition	Reduce recurrent nail-breakage event frequency per person during a standardized observation period.
Primary endpoint	Between-group change difference or difference in event counts over the same prespecified period; rates separate if time at risk verified; not thickness, hardness, PGA or OGSS.
Comparator	Matched-background placebo, no treatment or usual care kept as separate contrasts; actual eligible comparison not verified.
Duplicate-detection key	`biotin\|sole-active-oral\|adult-brittle-nails\|finger-toe-unpooled\|deficiency-correction-excluded-status-unverified\|standard-window-recurrent-breakage-events\|matched-placebo-no-treatment-usual-care\|dose-window-unverified`

What the research actually shows

Patel’s 0–5 nail PGA grades peeling, fragility and surface severity, not repeated breakage events. Even the biotin-labeled arm used a Sesbania extract, so a sole-active effect cannot be isolated. The paper labels nail outcomes inconsistently as primary or secondary; registry history and the analysis plan were not verified. The recent Shemer retrospective comparison has indexed response categories, but its full text and exact breakage-event ascertainment were not verified. Failure to retrieve full registry records was not counted as a negative result. A collagen report of improved breakage frequency concerns a different substance and was not used as biotin efficacy.

Why this is classified as ?

Within the documented search, no directly eligible human comparative result was verified for sole-active oral biotin reducing breakage-event frequency over a standardized observation window. The ? grade and null score do not mean no effect or no studies worldwide.

Counterpoint. The recent Shemer retrospective comparison has indexed response categories, but its full text and exact breakage-event ascertainment were not verified. Failure to retrieve full registry records was not counted as a negative result. A collagen report of improved breakage frequency concerns a different substance and was not used as biotin efficacy.

Rejudgment record. No directly eligible event-frequency result verified — Original rubric stage zero; bounded by the documented search

Stored scoring profile

Endpoint

Symptom or function itself is the target - including patient reports and performance tests

Stored derived and displayed grades match; this is not a current recalculation or validity check (?).

✓

Review performed and remaining limitations

Twelve-axis boundaries were checked against records 866, 009, 1639 and 3103, separating thickness, hardness, severity, responder proportions and collagen breakage-frequency data

Eligible formulation, dose, duration, event definition, observation time, number of nails, population criteria, baseline status, arm denominators, between-group effect, CI, P value and MCID remain unverified

Evidence Table

Study	Design	Sample	Funding	Endpoint	Result	Weight
Colombo 1990	Nonrandomized microscopy before/after study; healthy comparator not matched randomized treatment control	See numeric_evidence for study denominators; target-event denominators unverified.	See trial_families and evidence_appraisal for funding, products and COI; unknown funding is not independence.	Thickness and scanning-electron-microscopy surface morphology	Wrong endpoint and uncontrolled treatment-effect comparison	Excluded from direct efficacy grading
Hochman 1993	Retrospective uncontrolled response evaluation	See numeric_evidence for study denominators; target-event denominators unverified.	See trial_families and evidence_appraisal for funding, products and COI; unknown funding is not independence.	Subjective hardness and splitting response	No prespecified repeated-event window or between-group result	Excluded from direct efficacy grading
Floersheim 1989	Clinical treatment series; comparator not established by abstract	See numeric_evidence for study denominators; target-event denominators unverified.	See trial_families and evidence_appraisal for funding, products and COI; unknown funding is not independence.	Firmer/harder subjective response after variable treatment duration	Uncontrolled response categories, not recurring breakages/person-time	Excluded from direct efficacy grading
Chiavetta 2019	Randomized open treatment, assessor-blinded parallel add-on study	See numeric_evidence for study denominators; target-event denominators unverified.	See trial_families and evidence_appraisal for funding, products and COI; unknown funding is not independence.	Primary OGSS severity; secondary lamellar-splitting severity and responder thresholds; not breakage-event count	Outcome mismatch; toe site kept separate, no conversion to finger events	Excluded from direct efficacy grading
Shemer 2025	Indexed abstract describes retrospective comparison; full methods inaccessible	See numeric_evidence for study denominators; target-event denominators unverified.	See trial_families and evidence_appraisal for funding, products and COI; unknown funding is not independence.	Complete/partial response categories in indexed abstract; actual repeated-event capture unverified	Does not provide a verified target comparator/result; access limitation not negative evidence	Excluded from direct efficacy grading
Patel 2025 botanical extract trial	Randomized double-blind placebo-controlled; withdrawals excluded	See numeric_evidence for study denominators; target-event denominators unverified.	See trial_families and evidence_appraisal for funding, products and COI; unknown funding is not independence.	Nail PGA peeling/roughness severity; paper inconsistently labels nail primary/secondary	Wrong intervention attribution and ordinal severity rather than standardized breakage events	Excluded from direct efficacy grading
Hexsel 2017 collagen peptides	Uncontrolled open-label before/after	See numeric_evidence for study denominators; target-event denominators unverified.	See trial_families and evidence_appraisal for funding, products and COI; unknown funding is not independence.	Reported frequency of broken nails and growth	Wrong active substance; within-group frequency does not establish a biotin comparative effect	Excluded from direct efficacy grading
NCT05800496	Registry discovery only, not fully retrievable	See numeric_evidence for study denominators; target-event denominators unverified.	See trial_families and evidence_appraisal for funding, products and COI; unknown funding is not independence.	Indexed PGA severity wording; actual event endpoint/results not verified	No verified eligible result; do not treat as negative or terminated	Excluded from direct efficacy grading
NCT07373574	Registry discovery only, not fully retrievable	See numeric_evidence for study denominators; target-event denominators unverified.	See trial_families and evidence_appraisal for funding, products and COI; unknown funding is not independence.	Nails/hair named, event definition/results not verified	No verified eligible result; status/timing not inferred from record number	Excluded from direct efficacy grading

Receipt — 15 References

Evidence access cutoff: 2026-09-15. Each citation states its actual access level (full-text transcription, abstract, index, or other) and remaining limitations. Bibliographic checking does not certify the study results or treatment efficacy.

The Role of Sesbania grandiflora-Derived Biotin and Bambusa arundinacea-Derived Silica Extracts in Promoting Hair, Skin, and Nail Health (Patel et al., 2025)

Biotin , sole-active oral product,does it really help with Reduction of recurrent brittle-nail breakage events over a standardized observation period?